Taking a Walk ("If Winter Comes" No. 6)

Adrian sweated quite a bit last night. At 3 am the nurse came in to do the blood works, which later showed his WBC had gone up to a whopping 10.3! Thanks to the injection he's getting and the steroids he's on. The steroids are also helping to keep fever away, got to wait and see if it comes back when he gets off them.

One of the doctors came by this afternoon and he said it's not likely that he would get the fever back. I would hate for those rigors to come back...

After lunch he took a shower, bless him, he's sooo weak. But he's a champ and tries his heart out to do things. Then we all went for a walk downstairs – him in a wheelchair. Outside was gorgeous and he walked for about 20 min, we are not talking power walking but he did so well. Then we went back upstairs and he went to sleep.

I hope that tomorrow will bring more medical info, Dr. Hellerstedt is back and it would be lovely to find out if we can go to Houston this week. I just want to be sure that they feel like they are giving the right chemo and if they want to change it, rather it happens now than in a few months.

"If Winter Comes," A blog about anaplastic large cell lymphoma"

This blog follows the journey undertaken by my husband, by me, and by our family as my husband battles a disease we never saw coming: Recently he was diagnosed with a rare subtype of T-cell non-Hodgkin's lymphoma known as Anaplastic Large Cell Lymphoma ALK+. He is only 32 years old.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap